tag:blogger.com,1999:blog-9551150.post199334543763528594..comments2024-03-28T01:27:23.408-04:00Comments on Health Care Renewal: "Can't This be Avoided?" - How Corporate Marketers Manipulated a Clinical Research Report to Avoid "Undermining" Marketing MessagesRoy M. Poses MDhttp://www.blogger.com/profile/00497209843184497847noreply@blogger.comBlogger2125tag:blogger.com,1999:blog-9551150.post-18892640273821791342015-10-15T13:39:33.028-04:002015-10-15T13:39:33.028-04:00Thank you for scrutinizing the clinical trials pro...Thank you for scrutinizing the clinical trials processes of the FDA. In case you missed it, the Project On Government Oversight just published a report on dangerous decision making at the FDA, focusing on the agency's handling of (the blood-thinner) Pradaxa: http://www.pogo.org/our-work/reports/2015/drug-problems-dangerous-fda-decision-making.html<br />Anonymousnoreply@blogger.comtag:blogger.com,1999:blog-9551150.post-13970787366851974772014-02-14T19:03:59.320-05:002014-02-14T19:03:59.320-05:00I had a patient die from bleeding on pradaxa when ...I had a patient die from bleeding on pradaxa when its levles went sky high due to in inrpteraction with an a fib drug, multaq, that had not been previously recognized. I advised the FDA to pull the drug until such needless deaths were worked out and understood, but it did nothing. Six months later, the drug interaction was mentioned on the labrels of both drugs.Anonymousnoreply@blogger.com